Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Nemonoxacin in Diabetic Foot Infections
NCT00685698Phase 2Completed
- Sponsor
- TaiGen Biotechnology Co., Ltd.
- Start
- Jun 2008
- Primary completion
- Apr 2009
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
A Phase 2 trial of nemonoxacin in diabetic foot infection (DFI), sponsored by TaiGen Biotechnology Co., Ltd.. Started Jun 2008; status: completed.
02
Drugs
nemonoxacin
03
Conditions
diabetic foot infection (DFI)
Beyond the preview
Go deeper on NCT00685698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00685698.